Abel López‐Bermejo
- Epidemiology top 10%
- Physiology top 10%
- Endocrinology, Diabetes and Metabolism top 10%
- Cardiology and Cardiovascular Medicine top 10%
- Molecular Biology
- Co-authors
- Wifredo RicartJosé Manuel Fernández‐RealRoser CasamitjanaJoan VendrellAntoni CastroGeorgina PeñarrojaCristóbal RichartMontserrat Broch
- Topics
- Adipokines, Inflammation, and Metabolic Diseases (10 papers)Diabetes and associated disorders (5 papers)Liver Disease Diagnosis and Treatment (4 papers)
In The Last Decade
Abel López‐Bermejo
19 papers receiving 906 citations
Peers
Comparison fields: 5 of 82
- Epidemiology 468
- Physiology 233
- Endocrinology, Diabetes and Metabolism 182
- Cardiology and Cardiovascular Medicine 166
- Molecular Biology 163
Countries citing papers authored by Abel López‐Bermejo
This map shows the geographic impact of Abel López‐Bermejo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abel López‐Bermejo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abel López‐Bermejo more than expected).
Fields of papers citing papers by Abel López‐Bermejo
This network shows the impact of papers produced by Abel López‐Bermejo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abel López‐Bermejo. The network helps show where Abel López‐Bermejo may publish in the future.
Co-authorship network of co-authors of Abel López‐Bermejo
This figure shows the co-authorship network connecting the top 25 collaborators of Abel López‐Bermejo. A scholar is included among the top collaborators of Abel López‐Bermejo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abel López‐Bermejo. Abel López‐Bermejo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 16 | |
| 2 | 6 | |
| 3 | 78 | |
| 4 | 35 | |
| 5 | 43 | |
| 6 | 11 | |
| 7 | 12 | |
| 8 | 129 | |
| 9 | 27 | |
| 10 | 26 | |
| 11 | 34 | |
| 12 | 15 | |
| 13 | 98 | |
| 14 | 81 | |
| 15 | 11 | |
| 16 | 82 | |
| 17 | 142 | |
| 18 | 25 | |
| 19 | 69 |
About Abel López‐Bermejo
Abel López‐Bermejo is a scholar working on Endocrine and Autonomic Systems, Epidemiology and Cardiology and Cardiovascular Medicine, having authored 19 papers that have together received 940 indexed citations. Recurring topics across this work include Adipokines, Inflammation, and Metabolic Diseases (10 papers), Diabetes and associated disorders (5 papers) and Liver Disease Diagnosis and Treatment (4 papers). The work is most often cited by research in Epidemiology (468 citations), Hematology (141 citations) and Endocrine and Autonomic Systems (76 citations). Abel López‐Bermejo has collaborated with scholars based in Spain, France and Japan. Frequent co-authors include Wifredo Ricart, José Manuel Fernández‐Real, Roser Casamitjana, Joan Vendrell, Antoni Castro, Georgina Peñarroja, Cristóbal Richart, Montserrat Broch, Eduardo Esteve and Patricia Botas. Their work appears in journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes Care and Hypertension.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.